TAT and amyotrophic lateral sclerosis: In this study, we demonstrated that intranasal administration of NAC, which has low transferability from the blood to the brain and spinal cord, extensively extended the survival of G93A mice (an ALS animal model) when combined with a PEG-PCL-Tat nanocarrier.